Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “MALIGNANT PLEURAL MESOTHELIOMA”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT03683680
What this trial is testing

Prospectively Collected Pleural Biopsies for Validation of Malignant Pleural Mesothelioma Prognostic Biomarkers

Who this might be right for
Mesothelioma
Dana-Farber Cancer Institute 240
Testing effectiveness (Phase 2)Study completedNCT00309946
What this trial is testing

Cediranib Maleate in Treating Patients With Malignant Mesothelioma That Cannot Be Removed By Surgery

Who this might be right for
Advanced Malignant MesotheliomaEpithelial MesotheliomaLocalized Malignant Mesothelioma+2 more
National Cancer Institute (NCI) 51
Testing effectiveness (Phase 2)Looking for participantsNCT05932199
What this trial is testing

Neoadjuvant Durvalumab and Tremelimumab With and Without Chemotherapy for Mesothelioma

Who this might be right for
Mesothelioma
Baylor College of Medicine 52
Early research (Phase 1)Study completedNCT00003046
What this trial is testing

Interleukin-12 in Treating Patients With Cancer in the Abdomen

Who this might be right for
Anal CancerColorectal CancerGallbladder Cancer+2 more
M.D. Anderson Cancer Center 29
Testing effectiveness (Phase 2)Study completedNCT00054002
What this trial is testing

Surgery and Photodynamic Therapy in Treating Patients With Malignant Mesothelioma

Who this might be right for
Malignant Mesothelioma
Roswell Park Cancer Institute 12
Testing effectiveness (Phase 2)Study completedNCT04177953
What this trial is testing

Nivolumab With Chemotherapy in Pleural Mesothelioma After Surgery

Who this might be right for
Pleural Mesothelioma Malignant
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 92
Testing effectiveness (Phase 2)Active Not RecruitingNCT06155279
What this trial is testing

Induction Chemo+Immunotherapy in Resectable Epithelioid and Biphasic Pleural Mesothelioma (CHIMERA Study)

Who this might be right for
Pleural Mesothelioma
Istituto Oncologico Veneto IRCCS 41
Testing effectiveness (Phase 2)Study completedNCT02899195
What this trial is testing

Phase II MEDI4736 in Combination With Chemotherapy for First-Line Treatment of Unresectable Mesothelioma

Who this might be right for
MesotheliomaPleural Mesothelioma
PrECOG, LLC. 55
Testing effectiveness (Phase 2)Temporarily pausedNCT01627795
What this trial is testing

Safety and Efficacy of Oshadi D and Oshadi R for Malignant Mesothelioma Treatment

Who this might be right for
Mesothelioma
Oshadi Drug Administration 17
Testing effectiveness (Phase 2)Study completedNCT00541073
What this trial is testing

Pemetrexed, Cisplatin, and Vitamin B12 in Treating Patients With Mesothelioma of the Chest That Cannot Be Removed by Surgery

Who this might be right for
Malignant Mesothelioma
Centre Oscar Lambret 60
Early research (Phase 1)Ended earlyNCT03436732
What this trial is testing

Mesothelin-Targeted Immunotoxin LMB-100 in Combination With SEL-110 in Subjects With Malignant Pleural or Peritoneal Mesothelioma

Who this might be right for
Mesothelioma
National Cancer Institute (NCI) 5
Testing effectiveness (Phase 2)UnknownNCT01869023
What this trial is testing

Phase II Study of Six Hours Low Dose Gemcitabine Plus Cisplatin in the Treatment for Advanced Pleural Mesothelioma

Who this might be right for
Advanced Malignant Pleural Mesothelioma
Instituto Nacional de Cancerologia de Mexico 26
Not applicableStudy completedNCT02269878
What this trial is testing

Effect of FAS and FAS Ligand Polymorphisms on Patients With Platinum-Based -Treated Malignant Pleural Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
Ain Shams University 68
Early research (Phase 1)Looking for participantsNCT05304208
What this trial is testing

DENdritic Cell Therapy Combined With SURgEry in Mesothelioma

Who this might be right for
Mesotheliomas Pleural
Erasmus Medical Center 16
Not applicableLooking for participantsNCT06910449
What this trial is testing

Hemithoracic Arc Radiotherapy Post Pleural Decortication

Who this might be right for
Malignant Pleural Mesothelioma
Cairo University 45
Testing effectiveness (Phase 2)Ended earlyNCT03393858
What this trial is testing

Combination of Immunotherapy and Hyperthermia in Advanced Malignant Mesothelioma

Who this might be right for
CancerMesothelioma, Malignant
Capital Medical University 10
Early research (Phase 1)Study completedNCT03054298
What this trial is testing

CAR T Cells in Mesothelin Expressing Cancers

Who this might be right for
Lung AdenocarcinomaOvarian CancerPeritoneal Carcinoma+3 more
University of Pennsylvania 65
Early research (Phase 1)Study completedNCT01997190
What this trial is testing

Intrapleural AdV-tk Therapy in Patients With Malignant Pleural Effusion

Who this might be right for
Malignant Pleural EffusionLung CancerMesothelioma+2 more
Candel Therapeutics, Inc. 19
Not applicableStudy completedNCT00372840
What this trial is testing

Printed Education Materials in Patients Who Are Finishing Treatment for Stage I, Stage II, or Stage IIIA Breast Cancer, Colorectal Cancer, Prostate Cancer, or Chest Cancer

Who this might be right for
Breast CancerColorectal CancerLung Cancer+4 more
Fox Chase Cancer Center 340
Testing effectiveness (Phase 2)Study completedNCT01590160
What this trial is testing

Ganetespib With Platinum, in Patients With Malignant Pleural Mesothelioma

Who this might be right for
Lung Cancer - Malignant Pleural Mesothelioma
University College, London 27
Next Page